These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25904519)

  • 1. Emergence of daptomycin-resistant Enterococcus faecium in a critically ill patient with postoperative intra-abdominal sepsis.
    Ballester F; Pujol I; Cueto P; Rovira C; Iftimie S; Camps J
    Rev Esp Quimioter; 2015 Apr; 28(2):109-10. PubMed ID: 25904519
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
    Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of resistance to daptomycin in Enterococcus faecium.
    Montero CI; Stock F; Murray PR
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1167-70. PubMed ID: 18180351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of daptomycin β-Lactam combination therapy to prevent resistance emergence in Enterococcus faecium.
    Menon V; Davis R; Shackel N; Espedido BA; Beukers AG; Jensen SO; van Hal SJ
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):120-122. PubMed ID: 29195768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.
    Fraher MH; Corcoran GD; Creagh S; Feeney E
    J Hosp Infect; 2007 Apr; 65(4):376-8. PubMed ID: 17316896
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract]   [Full Text] [Related]  

  • 7. De novo daptomycin nonsusceptibility in a clinical isolate.
    Lesho EP; Wortmann GW; Craft D; Moran KA
    J Clin Microbiol; 2006 Feb; 44(2):673. PubMed ID: 16455945
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis.
    Egli A; Schmid H; Kuenzli E; Widmer AF; Battegay M; Plagge H; Frei R; Achermann R; Weisser M
    Clin Microbiol Infect; 2017 Feb; 23(2):118.e1-118.e7. PubMed ID: 27746397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
    Kebriaei R; Rice SA; Singh KV; Stamper KC; Dinh AQ; Rios R; Diaz L; Murray BE; Munita JM; Tran TT; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760141
    [No Abstract]   [Full Text] [Related]  

  • 10. Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.
    Woods RJ; Patel TS; Nagel JL; Newton DW; Read AF
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):226-228. PubMed ID: 29331166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient.
    Sorlózano A; Panesso D; Navarro-Marí JM; Arias CA; Gutiérrez-Fernández J
    Rev Esp Quimioter; 2015 Aug; 28(4):207-9. PubMed ID: 26200029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.
    Lewis JD; Enfield KB; Cox HL; Mathers AJ; Sifri CD
    Transpl Infect Dis; 2016 Jun; 18(3):341-53. PubMed ID: 26953719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo daptomycin-nonsusceptible enterococcal infections.
    Kelesidis T; Humphries R; Uslan DZ; Pegues D
    Emerg Infect Dis; 2012 Apr; 18(4):674-6. PubMed ID: 22469288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
    King ST; Usery JB; Holloway K; Koeth L; Cleveland KO; Gelfand MS
    J Antimicrob Chemother; 2011 Nov; 66(11):2673-5. PubMed ID: 21846674
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe sepsis caused by a linezolid-resistant Enterococcus faecium in a 10-year-old girl after multiple trauma.
    Mutschler M; Trojan S; Defosse JM; Helmers A; Probst C; Bouillon B; Wappler F; Sakka SG
    Int J Infect Dis; 2013 Jun; 17(6):e466-7. PubMed ID: 23415582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates.
    Sinel C; Jaussaud C; Auzou M; Giard JC; Cattoir V
    Int J Antimicrob Agents; 2016 Oct; 48(4):449-52. PubMed ID: 27546218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.
    Wang G; Kamalakaran S; Dhand A; Huang W; Ojaimi C; Zhuge J; Yee LL; Mayigowda P; Surendraiah PK; Dimitrova N; Fallon JT
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4848-54. PubMed ID: 24913170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H; Azap OK; Ergin F; Karaman SO; Oruç E
    Int J Antimicrob Agents; 2004 Jun; 23(6):642-3. PubMed ID: 15194140
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
    Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of enterococci to daptomycin is dependent upon testing methodology.
    Bryant KA; Roberts AL; Rupp ME; Anderson JR; Lyden ER; Fey PD; Van Schooneveld TC
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):497-501. PubMed ID: 23719086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.